Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer
(2012) In American Journal of Epidemiology 175(7). p.685-695- Abstract
- Cutaneous human papillomaviruses (HPVs) have been associated with squamous cell carcinoma (SCC) in case-control studies, but there are limited data from prospective studies assessing whether virus exposure predicts risk of future cancer development. Two major biobanks, the Southern Sweden Microbiology Biobank (1971-2003) and the Janus Biobank (1973-2003) in Norway, containing samples from 850,000 donors, were searched for incident skin cancer for up to 30 years using registry linkages. Altogether, 2,623 donors with samples taken before diagnosis of SCC or basal cell carcinoma (BCC) of the skin were identified. Prediagnostic samples and samples from 2,623 matched controls were tested for antibodies against 33 types of HPV. Baseline... (More)
- Cutaneous human papillomaviruses (HPVs) have been associated with squamous cell carcinoma (SCC) in case-control studies, but there are limited data from prospective studies assessing whether virus exposure predicts risk of future cancer development. Two major biobanks, the Southern Sweden Microbiology Biobank (1971-2003) and the Janus Biobank (1973-2003) in Norway, containing samples from 850,000 donors, were searched for incident skin cancer for up to 30 years using registry linkages. Altogether, 2,623 donors with samples taken before diagnosis of SCC or basal cell carcinoma (BCC) of the skin were identified. Prediagnostic samples and samples from 2,623 matched controls were tested for antibodies against 33 types of HPV. Baseline seropositivity to HPV types in genus beta species 2 was associated with SCC risk (odds ratio = 1.3, 95% confidence interval: 1.1, 1.7); this was also the case for samples taken more than 18 years before diagnosis (odds ratio = 1.8, 95% confidence interval: 1.1, 2.8). Type-specific persistent seropositivity entailed elevated point estimates for SCC risk for 29 HPV types and decreased point estimates for only 3 types. After multiple hypothesis adjustment, HPV 76 was significantly associated with SCC risk and HPV 9 with BCC risk. In summary, seropositivity for certain HPV types was associated with an increased risk for future development of SCC and BCC. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2574791
- author
- Andersson, Kristin LU ; Michael, Kristina M. ; Luostarinen, Tapio ; Waterboer, Tim ; Gislefoss, Randi ; Hakulinen, Timo ; Forslund, Ola LU ; Pawlita, Michael and Dillner, Joakim LU
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- beta papillomavirus, DNA tumor viruses, human papillomavirus
- in
- American Journal of Epidemiology
- volume
- 175
- issue
- 7
- pages
- 685 - 695
- publisher
- Oxford University Press
- external identifiers
-
- wos:000302483500013
- scopus:84859486629
- pmid:22419740
- ISSN
- 0002-9262
- DOI
- 10.1093/aje/kwr373
- language
- English
- LU publication?
- yes
- id
- bc32d443-fe0c-4f44-8550-bc11fdea06e9 (old id 2574791)
- date added to LUP
- 2016-04-01 09:59:39
- date last changed
- 2022-04-27 17:34:38
@article{bc32d443-fe0c-4f44-8550-bc11fdea06e9, abstract = {{Cutaneous human papillomaviruses (HPVs) have been associated with squamous cell carcinoma (SCC) in case-control studies, but there are limited data from prospective studies assessing whether virus exposure predicts risk of future cancer development. Two major biobanks, the Southern Sweden Microbiology Biobank (1971-2003) and the Janus Biobank (1973-2003) in Norway, containing samples from 850,000 donors, were searched for incident skin cancer for up to 30 years using registry linkages. Altogether, 2,623 donors with samples taken before diagnosis of SCC or basal cell carcinoma (BCC) of the skin were identified. Prediagnostic samples and samples from 2,623 matched controls were tested for antibodies against 33 types of HPV. Baseline seropositivity to HPV types in genus beta species 2 was associated with SCC risk (odds ratio = 1.3, 95% confidence interval: 1.1, 1.7); this was also the case for samples taken more than 18 years before diagnosis (odds ratio = 1.8, 95% confidence interval: 1.1, 2.8). Type-specific persistent seropositivity entailed elevated point estimates for SCC risk for 29 HPV types and decreased point estimates for only 3 types. After multiple hypothesis adjustment, HPV 76 was significantly associated with SCC risk and HPV 9 with BCC risk. In summary, seropositivity for certain HPV types was associated with an increased risk for future development of SCC and BCC.}}, author = {{Andersson, Kristin and Michael, Kristina M. and Luostarinen, Tapio and Waterboer, Tim and Gislefoss, Randi and Hakulinen, Timo and Forslund, Ola and Pawlita, Michael and Dillner, Joakim}}, issn = {{0002-9262}}, keywords = {{beta papillomavirus; DNA tumor viruses; human papillomavirus}}, language = {{eng}}, number = {{7}}, pages = {{685--695}}, publisher = {{Oxford University Press}}, series = {{American Journal of Epidemiology}}, title = {{Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer}}, url = {{https://lup.lub.lu.se/search/files/1461373/3054612.pdf}}, doi = {{10.1093/aje/kwr373}}, volume = {{175}}, year = {{2012}}, }